Journal: Communications Medicine
Article Title: Targeting and dissociating HIF2α from the molecular chaperone Hsp70 triggers apoptosis in kidney cancer
doi: 10.1038/s43856-025-01356-x
Figure Lengend Snippet: a Caki-2 cells were treated with 30 μM Compound-c2 for the indicated durations. The stability of HIF1α was assessed by immunoblotting. β-actin was used as a loading control. LE Long Exposure, SE Short Exposure. b Lysate from 786-O cells was challenged with the indicated amounts of Biotin-Compound-c2 for 1 h. HIF2α binding and input was assessed by immunoblotting. c Empty vector (EV) and HA-HIF2α were transiently expressed in HEK293 cells and lysates were challenged with the indicated amounts of Biotin-Compound-c2 for 1 h. HIF2α binding to Compound-c2 was assessed by immunoblotting. d Amino acid sites of the HIF2α PAS-B domain predicted to contact Compound-c2. Residues shown are those within 3.5 Å of the docked model of Compound-c2. e HEK293 cells were transiently transfected with indicated HA-HIF2α mutants. Lysates were challenged with 1 µM of Biotin-Compound-c2 for 1 h and HIF2α binding to Compound-c2 was assessed by immunoblotting. Densitometry was performed using Photoshop v.23.5.1 to quantify Western blot band signal intensity. Bars represent the mean signal intensity values of HIF2α pulldown:HIF2α input compared to that of WT for three independent measurements. Error bars represent the standard deviation (S.D.) of three independent measurements. A Student’s t test (two-sided) was performed to assess statistical significance compared to WT control (NS- not significant). (See also Fig. S3B-C).
Article Snippet: Cultured human embryonic kidney (HEK293) (ATCC, Cat# CRL-1573; RRID:CVCL_0045), (Human, unknown) and HK-2 (ATCC, Cat# CRL-2190; RRID:CVCL_0302), (Human, Male) cells were grown in Dulbecco’s Modified Eagle Medium (DMEM, Sigma-Aldrich), 786-O cells (ATCC Cat# CRL-1932; RRID:CVCL_1051), (Human, Male) OS-RC-2 (RIKEN Cell Bank, Tsukuba, Japan, RRID:CVCL_1626) cells (Human, Male), and TUHR14TKB (RIKEN Cell Bank, Tsukuba, Japan, RRID:CVCL_5953) cells (Human, Male) in Roswell Park Memorial Institute (RPMI)1640 Medium (Sigma-Aldrich), A498 cells (ATCC Cat# CRL-44; RRID:CVCL_1056), (Human, Female) in Minimum Essential Medium (MEM, Sigma-Aldrich), Caki-1 (ATCC Cat# HTB-46; RRID:CVCL_0234), (Human, Male) and Caki-2 cells (ATCC Cat# HTB-47; RRID:CVCL_0235), (Human, Male) in McCoy’s 5 A Medium (Sigma-Aldrich) all supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich).
Techniques: Western Blot, Control, Binding Assay, Plasmid Preparation, Transfection, Standard Deviation